[1]
Morita, J. et al. 2013. Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. Canadian Urological Association Journal. 7, 5-6 (May 2013), e351–4. DOI:https://doi.org/10.5489/cuaj.1210.